baber/WOPTO huggingface dataset:
Patent AU-2021204872-A1 (AU)
Title: Method of determining damage to parts of a vehicle
Inventor: RANCA RAZVAN
IPC: G06Q10/00
Filed: 2021-01-04
Abstract: The present invention relates to the determination of damage to portions of a vehicle. More particularly, the present invention relates to determining whether each part of a vehicle should be classified as damaged or undamaged and optionally the severity of the damage to each part of the damaged vehicle. Aspects and/or embodiments seek to provide a computer-implemented method for determining damage states of each part of a damaged vehicle, indicating whether each part of the vehicle is damaged or undamaged and optionally the severity of the damage to each part of the damaged vehicle, using images of the damage to the vehicle and trained models to assess the damage indicated in the images of the damaged vehicle.
Patent AU-2021205451-A1 (AU)
Title: Therapeutic engineered microbial cell systems and methods for treating hyperuricemia and gout
Inventor: GEISLER CHRISTOPH
IPC: A61P3/00
Filed: 2021-01-08
Abstract: The present disclosure relates to engineered microbial cells that have been engineered to include a uricase, a uric acid transporter, or both a uricase and a uric acid transporter. The engineered microbial cells of the present disclosure are useful in degrading uric acid inside the engineered microbial cell. The engineered microbial cells of the present disclosure are useful in methods of treating hyperuricemia. The engineered microbial cells of the present disclosure are also useful in methods of treating gout, and in particular chronic refractory gout.
Patent AU-2021209391-A1 (AU)
Title: Volume heat treatment method and related system
Inventor: KUPISIEWICZ AXEL STEFAN M
IPC: C21D1/773
Filed: 2021-01-22
Abstract: Disclosed is a method for volume heat treatment of a part (2) having an outer surface (22) delimiting its volume, the method comprising the following steps: a. providing a laser source (3); b. providing the part (2); c. providing support means (4) for supporting the part (2); d. positioning the part (2) such that it is held in position by the support means (4); e. irradiating at least one portion (23) of the outer surface (22) of the part (2) with the laser source (3) at a laser power and for a laser exposure time in order to obtain an increase in temperature in substantially the whole of the volume of the part (2).
Patent AU-2021211397-A1 (AU)
Title: Use of anti-aging glycopeptides for inhibition of immune rejection of a graft
Inventor: YOUNG LACHLAN GRANT
IPC: A61K38/14
Filed: 2021-01-22
Abstract: The present document describes uses and methods of using a gem-difluorinated C-glycopeptide compound of general formula I, or a pharmaceutically acceptable base, addition salt with an acid, hydrate or solvate of the compound of general formula I for inhibition or prevention of immune rejection of an isolated graft contacted with said compound, prior to transplantation in a subject in need thereof.
Patent AU-2021229172-A1 (AU)
Title: Thermal Inverter Box
Inventor: KOEKKOEK RUDOLF
IPC: C01B3/04
Filed: 2021-08-25
Abstract: The invention relates to a thermal converter (1, 2) for generating from a parent compound a 
5 first fluid of first molecules (H2) with a first molecular weight and a second fluid of second 
molecules (02) with a second molecular weight, whereby the first molecular weight of the 
first molecules (H2) is less than the second molecular weight of the second molecules (02).  
In order to improve the efficiency of the thermal converter, the thermal converter comprises 
0 a spray device (18) for generating from the parent compound in fluid form a spray, which is 
supplied to a reaction device (1) for splitting the parent compound into a mixture compound 
of the first molecules (H2) and the second molecules (02).  
18005897_1 (GHMatters) P117138.AU
Patent AU-2021244562-A1 (AU)
Title: Systems and methods to produce tissue imaging biomarkers
Inventor: ST PIERRE SHAWN
IPC: G06T7/00
Filed: 2021-03-24
Abstract: Systems and methods for mapping a region of interest within breast tissue utilize multiple layers of information to produce a unique digital fingerprint of breast tissue. X-ray and ultrasound imaging is combined with elastography and Doppler to create an architectural map of a breast including coordinates to mark one or more regions of interest. The architectural map can be utilized during future imaging procedures and surgeries to automatically and virtually indicate the location of previously biopsied lesions. The architectural map can be displayed on a user interface of a computing device to guide a user to the region of interest during imaging.
Patent AU-2021247271-A1 (AU)
Title: Methods of treating systemic sclerosis
Inventor: PELOSO PAUL
IPC: C07D209/42
Filed: 2021-04-02
Abstract: Provided is a method of treating systemic sclerosis in a patient in need thereof, comprising administering to the patient a therapeutically effective amount of 2-(4-methoxy-3-(3-methylphenethoxy)benzamido)-2,3-dihydro-1H-indene-2-carboxylic acid (Compound 1), or a pharmaceutically acceptable salt thereof, for a dosing period of at least about 24 consecutive weeks.
Patent AU-2021250903-A1 (AU)
Title: Methods and systems for automatically matching audio content with visual input
Inventor: STEFFENSEN PETER BERG
IPC: G10H1/36
Filed: 2021-10-13
Abstract: A method and system for automatically matching audio content 
with visual input by obtaining a video (18) or image(s) (3) 
5 from a digital camera (39), analyzing the video (18) or 
image(s) (3) to extract image label(s) (8), mapping the image 
label(s) (8) to predefined input-output relationships (7) to 
determine a set of input feature values (9A), and selecting 
a set of music tracks (10) from a plurality of music tracks 
10 (4) stored on a storage device (3) having associated semantic 
feature values (5A) most closely matching the determined input 
feature values (9A) to create a playlist (12).  
It is suggested that Fig. 1 is published with the abstract.  
15
1/6 
1 
4 5A 5 
30 
PLAYLIST 10 
3 8 9A 
X1 X2 .. Xn 
IlMG LAB 
1 
6 5A 
oLABEL#1 X1 
o LABEL #2 X2 
o LABEL #N X3 
FIG.1 
13 4 30 5 
3 8 8A 14 V 12 
0 ocean 99.8% upbeat 
upbeat 
excited PL 
o sky 99.1% happy 7 
o wave 98.7% spiritual 
o male 97.5% rebellious I/o 
0 ae9.%aggressive -1/ Vi] 
surf 89.3% tense 
1 reflective 
ecstatic • 
-MLI ---hopeful - 15 
6 houl 16 
0 hopeful 
6A 
FIG. 2
Patent AU-2021261471-A1 (AU)
Title: Coronavirus vaccine
Inventor: SAHIN UGUR
IPC: A61K39/12
Filed: 2021-04-16
Abstract: This disclosure relates to the field of RNA to prevent or treat coronavirus infection. In particular, the present disclosure relates to methods and agents for vaccination against coronavirus infection and inducing effective coronavirus antigen-specific immune responses such as antibody and/or T cell responses. These methods and agents are, in particular, useful for the prevention or treatment of coronavirus infection. Administration of RNA disclosed herein to a subject can protect the subject against coronavirus infection. Specifically, in one embodiment, the present disclosure relates to methods comprising administering to a subject RNA encoding a peptide or protein comprising an epitope of SARS-CoV-2 spike protein (S protein) for inducing an immune response against coronavirus S protein, in particular S protein of SARS-CoV-2, in the subject, i.e., vaccine RNA encoding vaccine antigen. Administering to the subject RNA encoding vaccine antigen may provide (following expression of the RNA by appropriate target cells) vaccine antigen for inducing an immune response against vaccine antigen (and disease-associated antigen) in the subject. In December 2019, a pneumonia outbreak of unknown cause occurred in Wuhan, China and it became clear that a novel coronavirus (severe acute respiratory syndrome coronavirus 2; SARS-CoV-2) was the underlying cause. The genetic sequence of SARS-CoV-2 became available to the WHO and public (MN908947.3) and the virus was categorized into the betacoronavirus subfamily. By sequence analysis, the phylogenetic tree revealed a closer relationship to severe acute respiratory syndrome (SARS) virus isolates than to another coronavirus infecting humans, namely the Middle East respiratory syndrome (MERS) virus. On February 2nd, a total of 14'557 cases were globally confirmed in 24 countries including Germany and a subsequent self-sustaining, human-to-human virus spread resulted in that SARS-CoV-2 became a global epidemic.
Patent AU-2021269432-A1 (AU)
Title: Method for detecting the presence of a hypervirulent Clostridium difficile strain
Inventor: KIRVESKARI JUHA
IPC: G01N33/569
Filed: 2021-11-19
Abstract: METHOD FOR DETECTING THE PRESENCE OF A HYPERVIRULENT 
CLOSTRIDIUM DIFFICILE STRAIN 
ABSTRACT 
The present invention provides a nucleic acid amplification based method for detecting a 
hypervirulent Clostridium difficile strain in a biological sample. The present invention is based 
on the use of oligonucleotide primers and probes specific to negative and positive markers in 
hypervirulent Clostridium difficile genome.
Patent AU-2021273980-A1 (AU)
Title: Methods and compositions to treat vascular leak
Inventor: SIMONS MICHAEL
IPC: C07K19/00
Filed: 2021-05-21
Abstract: Provided are anti-syndecan-2 antibodies and compositions comprising said antibody and methods useful for treating acute respiratory distress syndrome, including coronavirus disease 2019-induced acute respiratory distress syndrome, in a subject in need thereof. The method comprises administering to the subject an effective amount to treat the acute respiratory distress syndrome of an syndecan-2 disrupting agent. The syndecan-2 disrupting agents may include at least one of the anti-syndecan-2 antibodies and/or at least one syndecan-2 disrupting peptide.
Patent AU-2021277667-A1 (AU)
Title: Coordinating fund transfers between a gaming device and a gaming establishment account utilizing a mobile device
Inventor: SHEPHERD JEFFERY
IPC: G07F7/10
Filed: 2021-12-01
Abstract: OF THE DISCLOSURE 
A system that utilizes a mobile device and a funding instrument associated with an 
external funding source to first transfer funds from the external funding source to a gaming 
establishment account and then, responsive to a completion of the first transfer, automatically 
transfer funds from the gaming establishment account to an electronic gaming machine and/or a 
gaming table.
'/'IlU 
FIG. 1 
Banking 
Networks 122 
124 120 
Patron External 
Management Funding 
System System 
102 
SResort 
SWallet 
112+114 104 110 
Sports Retail Cashless 
Wagering Wallet Wagering 
Wallet Wallet 
118 
106 
Retail Point 108 
of Sale 
System 
116
Patent AU-2021277698-A1 (AU)
Title: Compositions and methods for treating Alzheimer's disease and Parkinson's disease
Inventor: SALENTINE CHRISTOPHER G
IPC: C07C317/32
Filed: 2021-12-01
Abstract: The present invention is directed to tablets for oral administration to a subject, 
comprising a therapeutically effective amount of SYN120 or a pharmaceutically acceptable 
salt thereof, wherein the tablet is substantially free of lactose. The present invention is also 
directed to methods for treating diseases or conditions including Alzheimer's disease and/or 
Parkinson's disease, comprising administering to a patient in need thereof tablets regarding 
the same.
Patent AU-2021346129-A1 (AU)
Title: Methods for treating multiple myeloma
Inventor: GIRGIS SUZETTE
IPC: A61K39/00
Filed: 2021-09-16
Abstract: Methods of treating a hematological malignancy using a GPRC5DxCD3 bispecific antibody are described. The hematological malignancy can be a relapsed or refractory multiple myeloma, and the GPRC5DxCD3 bispecific antibody can be talquetamab.
Patent AU-2021366379-A1 (AU)
Title: Articles for use in non-combustible aerosol provision systems
Inventor: JUMAN NADINE
IPC: A24D1/20
Filed: 2021-10-21
Abstract: An article for use with a non-combustible aerosol provision system, wherein the article comprises an aerosol-generating material prepared from one or more botanical materials, wherein at least one of the botanical materials has a fill value of greater than about 6 mL/g.
Patent AU-2021369747-A1 (AU)
Title: Pseudotyped particles, modified cells, related compositions, and related methods
Inventor: MILLAY DOUGLAS
IPC: A61K9/50
Filed: 2021-10-30
Abstract: Some embodiments of the invention include pseudotyped particles (e.g., pseudo typed exosomes, pseudotyped VSV, and pseudo typed lentiviruses) and modified cells. Other embodiments of the invention include compositions (e.g., pharmaceutical compositions) of pseudotyped particles (e.g., pseudotyped exosomes, pseudotyped VSV, and pseudotyped lentiviruses) and modified cells. Certain embodiments of the invention include methods of making pseudotyped particles (e.g., pseudotyped exosomes, pseudotyped VSV, and pseudotyped lentiviruses) and modified cells. Other embodiments of the invention include methods of administering pseudotyped particles (e.g., pseudotyped exosomes, pseudotyped VSV, and pseudotyped lentiviruses). Further embodiments of the invention include methods of administering pseudotyped particles (e.g., pseudotyped exosomes, pseudotyped VSV, and pseudotyped lentiviruses) to treat diseases (e.g., muscular dystrophy). Additional embodiments of the invention are also discussed herein.
Patent AU-2021372797-A1 (AU)
Title: 5alpha-hydroxy-6beta-[2-(1-h-imidazol-4-yl)-ethylamino]-cholestan-3beta-ol analogues and pharmaceutical compositions comprising same for use in the treatment of cancer
Inventor: SILVENTE STÉPHANE
IPC: A61K31/58
Filed: 2021-10-28
Abstract: The present invention relates to a novel compound of general formula (I), and/or a pharmaceutically acceptable salt of such a compound, a pharmaceutical composition comprising at least said compound, for use as a drug for shrinking cancerous tumours in mammals.
Patent WO-2023064999-A1 (WO)
Inventor: GORMAN SAMUEL KEITH
IPC: G06F30/3308
Filed: 2022-10-24
Abstract: La présente invention concerne, selon certains aspects, des procédés de fabrication de systèmes quantiques analogiques (AQSs). D'autres aspects de la présente invention concernent des procédés pour résoudre des problèmes de calcul à l'aide d'un AQS. Les procédés de fabrication d'un AQS comprennent la génération d'un hamiltonien basé sur un problème de calcul, qui peut être un problème d'optimisation ou un problème de simulation. En outre, le procédé comprend l'identification de paramètres de fabrication AQS sur la base d'un ou de plusieurs procédés de mesure identifiés et du hamiltonien. Enfin, un AQS peut être fabriqué sur la base des paramètres de fabrication identifiés. Un AQS peut être utilisé entre autres pour simuler une batterie ou des interfaces.
Patent AU-2022200496-A1 (AU)
Title: Remote LPWAN gateway with backhaul over a high-latency communication system
Inventor: NARDINI FLAVIA TATA
IPC: H04W84/18
Filed: 2022-01-27
Abstract: Some embodiments relate to methods and systems for a terrestrial data communication 
gateway device for satellite communication. An example gateway device has at least 
one processor and memory accessible to the at least one processor and is configured to 
perform a method comprising: operating a low power wide area network (LPWAN) 
wireless communication subsystem responsive to the at least one processor to allow 
wireless communication between the gateway device and the multiple remote devices; 
operating a satellite communication subsystem to allow high-latency wireless 
communication with at least one orbiting low earth orbit satellite; and operating the at 
least one processor to perform gateway server functions in relation to the multiple 
remote devices, wherein the server functions include executing multiple processing 
threads, the multiple processing threads including message processing threads to 
process messages communicated between the gateway device and the remote devices 
and communicated between the gateway device and the low earth orbit satellite.
Patent AU-2022201379-A1 (AU)
Title: Thermoelectric material
Inventor: WANG XIAOLIN
IPC: H01L35/16
Filed: 2022-02-28
Abstract: A composite thermoelectric material (100) comprising: a host matrix (102) comprising 
a semiconducting thermoelectric material; and amorphous particles (104) dispersed 
throughout the host matrix (102), wherein the host matrix (102) includes a 
polycrystalline structure (106) nucleated by the amorphous particles (104).
Patent AU-2022201915-A1 (AU)
Title: Engineered CRISPR-Cas9 nucleases with altered PAM specificity
Inventor: JOUNG J KEITH
IPC: C12N9/22
Filed: 2022-03-19
Abstract: Engineered CRISPR-Cas9 nucleases with altered and improved PAM specificities and their use in genomic 
engineering, epigenomic engineering, and genome targeting.
Patent AU-2022202667-A1 (AU)
Title: Modular exhaust aftertreatment subsystem
Inventor: WEBB CYNTHIA CHAFFIN
IPC: F01N3/20
Filed: 2022-04-21
Abstract: OF THE DISCLOSURE 
A modular exhaust subsystem for purifying an exhaust gas feedstream of a 
compression-ignition internal combustion engine upstream of a base exhaust 
aftertreatment system includes a selective catalytic reduction (SCR) catalyst, and a first 
exhaust gas sensor and a first temperature sensor that are arranged to monitor the SCR 
catalyst. A reductant delivery system is arranged to inject a reductant upstream of the 
SCR catalyst. A controller is in communication with an engine-out exhaust gas sensor, a 
second exhaust gas sensor and a second temperature sensor that are arranged to monitor 
the base exhaust aftertreatment system. The controller controls the reductant delivery 
system to inject the reductant into the exhaust gas feedstream upstream of the SCR 
catalyst based upon inputs from the first and second exhaust gas sensors, the engine-out 
exhaust gas sensor, and the first and second temperature sensors.  
18661434 1 (GHMatters) P118792.AU
C 
LO 
A II 
I - 7 
! r i 
N C 
I Ia 
T e4 
LiL 
CrCON QQ
Patent AU-2022204361-A1 (AU)
Title: Nitrogen utilisation modulation
Inventor: WESTWOOD CHARLOTTE
IPC: A61P1/14
Filed: 2022-06-22
Abstract: The invention relates to methods, uses and products for modulating nitrogen utilisation in 
animals.  
In particular the invention relates to methods, uses and products for reducing the proportion of 
total nitrogen excreted in the urine of an animal to the total nitrogen ingested by the animal.  
This invention has particular application to dairy cows although this should not be seen as 
limiting.  
41
Patent AU-2022209669-A1 (AU)
Title: T cells for use in therapy
Inventor: DEBETS JOHANNES EDUARD MARIA ANTONIUS
IPC: C07K14/47
Filed: 2022-01-21
Abstract: The invention provides inter alia an engineered T cell, wherein said T cell is engineered to express a T cell receptor (TCR) or an antibody-based receptor that binds to a T cell epitope of human ropporin-1A (ROPN1) or human ropporin-1B (ROPN1B); wherein said T cell epitope is selected from the group consisting of SEQ ID NO:4, SEQ ID NO:43, SEQ ID NO:23, SEQ ID NO:56 and SEQ ID NO:24.
Patent AU-2022222693-A1 (AU)
Title: Method for producing protein material
Inventor: MOLINA LUIS
IPC: A23J1/00
Filed: 2022-02-16
Abstract: The present disclosure relates to methods for treating at least one source of proteins, treated protein material obtainable by said method of treatment, and food compositions for animals, preferably for pets, including said treated protein material.
Patent AU-2022228117-A1 (AU)
Title: Oligonucleotides representing digital data
Inventor: OWEN NICHOLAS
IPC: C12Q1/68
Filed: 2022-09-07
Abstract: This disclosure relates to a method for creating an oligonucleotide sequence to 
represent digital data. A processor selects from a first set of multiple oligonucleotide 
sequences one oligonucleotide sequence for each of multiple parts of the data. The 
multiple oligonucleotide sequences are configured to generate an electric time-domain 
signal from one oligonucleotide sequence that is distinguishable from the electric time
domain signal from another oligonucleotide sequence. The electric time-domain signal 
is indicative of an electric characteristic of one or more nucleotides present in an 
electric sensor at any one point in time. The processor then combines the one 
oligonucleotide sequence for each of multiple parts of the data into a single 
oligonucleotide sequence that represents a single oligonucleotide molecule to encode 
the digital data.
Patent AU-2022246421-A1 (AU)
Title: Railroad virtual track block system
Inventor: SPECHT JERRY WADE
IPC: B61L23/16
Filed: 2022-10-06
Abstract: A method of railroad track control includes partitioning a physical track block into a 
plurality of virtual track blocks, the physical track block defined by first and second insulated 
joints disposed at corresponding first and second ends of a length of railroad track. The 
5 presence of an electrical circuit discontinuity in one of the plurality of virtual track blocks; is 
detected and in response a corresponding virtual track block position code indicating the 
presence of the discontinuity in the one of the plurality of virtual track blocks is generated.
Patent AU-2022247476-A1 (AU)
Title: Biodegradable and/or edible tableware
Inventor: CASHMORE STEPHEN ROLAND
IPC: A21C11/00
Filed: 2022-03-29
Abstract: Described is a method of forming a biodegradable and/or edible tableware that has a three dimensional shape in a two-step cooking process by first partially cooking a dough, that contains at least a flour and gelling agent, in a mould (subject to pressure and heat) and then baking the moulded tableware. The dough may include a sugar, and if present, is present at a ratio of the gelling agent to the sugar from 0.8: 1 to 1:0.8. The dough may include a vegetable oil as the gelling agent and if the gelling agent is a vegetable oil, the dough includes the addition of water.
Patent AU-2022249112-A1 (AU)
Title: Electrode leads having nerve cuffs and associated systems
Inventor: JENNEY CHRISTOPHER
IPC: A61N1/05
Filed: 2022-03-01
Abstract: An electrode that includes an elongate lead body and a nerve cuff. The nerve cuff may include a biologically compatible, elastic, electrically insulative cuff body configured to be circumferentially disposed around a nerve, first and second relatively wide electrically conductive contacts carried by the cuff body that are spaced from one another in the length direction and that extend in the width direction to such an extent that they extend completely around the cuff body inner lumen when the cuff body is in the pre-set furled shape, and a plurality of relatively narrow electrically conductive contacts carried by the cuff body that are spaced from one another in the width direction and are located between the first and second relatively wide electrically conductive contacts.
Patent AU-2022269414-A1 (AU)
Title: Method for inducing hypertrophic muscle fibers for industrial meat production
Inventor: TZAHOR ELDAD
IPC: C12N5/077
Filed: 2022-05-05
Abstract: A method of inducing multinucleated myotube formation is provided. The method comprising contacting myogenic precursor cells from a farmed animal with an Extracellular Regulated Signaling Kinase (ERK1/2) inhibitor and/or an upregulator of intracellular Ca 2+ and/or RXR/RAR agonists, enhancing fusion and myogenic maturation.
Patent AU-2022269633-A1 (AU)
Title: Methods and compositions for treating a premature termination codon-mediated disorder
Inventor: EIMON PETER M
IPC: C12N15/113
Filed: 2022-05-05
Abstract: The invention relates generally to expression vectors and pharmaceutical compositions comprising a first, second, and/or third modified tRNA and the use of expression vectors and pharmaceutical compositions to express in a mammalian cell a functional gene product encoded by a gene containing a premature termination codon and/or to treat a disorder mediated by a premature termination codon,